Primary Care Companion E-lert

09.16.13

The Primary Care Companion for
CNS Disorders

Register | Current Issue | Information for Authors | About E-Lerts

Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder: Results of a Pilot Study

Susan L. McElroy, MD; Anna I. Guerdjikova, PhD; Dennis D. Kim, MD; Colleen Burns, PhD; Raúl Harris-Collazo, PhD; Ronald Landbloom, MD; and Eduardo Dunayevich, MD

Major depressive disorder (MDD) and obesity are 2 important public health problems that frequently co-occur. This study evaluated the effect of 32-mg/d naltrexone sustained release and 360-mg/d bupropion sustained release in 25 overweight or obese female patients with MDD.

[Abstract] [Full Text]

For more free peer-reviewed articles, visit the Companion at psychiatrist.com/pcc. If you are having trouble reading this E-Lert, see psychiatrist.com/elerts/pcc091613/

  f
Like us on Facebook
  t
Follow us on Twitter

You are receiving this update as a benefit of your Psychiatrist.com membership.

To ensure delivery of these messages add psychcom@psychiatrist.com to your address book. If you would not like to receive further E-Lerts, go to www.psychiatrist.com/elerts and click the "Unsubscribe from E-Lerts" link. If you are having trouble unsubscribing, contact the web administrator for assistance.

If you are having trouble with your Psychiatrist.com membership, contact our circulation department. Direct any other questions or comments to the web administrator.

Physicians Postgraduate Press, Inc. | 850 Ridge Lake Boulevard, Suite 300 | Memphis, TN 38120

Please do not reply directly to this e-mail. Neither www.psychiatrist.com nor any of its family of websites will ask you to send us profile information via e-mail.

If you cannot read this, go to http://www.psychiatrist.com/elerts/pcc091613/.

© Copyright 2013, Physicians Postgraduate Press, Inc. All rights reserved.